Delivery Order SPE2DB24D1104-SPE2DB25FXWJ7
Award Date
1/10/25
Potential Completion Date
1/13/25
Potential Value
$1.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
Amerisourcebergen Drug Corp, through its Corporate Office division, has been awarded a firm fixed price delivery order by the Defense Logistics Agency (DLA) to provide 4,563,471,748 units of DEXAMETHASONE 20 MG/5 ML VIAL 5ML, a pharmaceutical product. The contract has a potential value of $2,317.07 and a completion date of January 30, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA, with a potential value of...
This is a delivery order awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4,565,911,624 units of Dexamethasone 20 mg/5 ml vials, a critical medication. The order has a firm fixed price of $5,562.90 and a completion date of September 24, 2024. Amerisourcebergen, through its extensive pharmaceutical supply chain, will provide this medication to support various military treatment...
This federal contract award, valued at $1,454.86, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of dexamethasone 10 mg/ml vials, a specialty medication used in various medical treatments.
This award is associated with a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award, with ID SPE2DB22D1106|SPE2DB25FDSQ6, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,067.77 delivery order contract is for the supply of 4566824170 DEXAMETHASONE 10 MG/ML VIALML, a pharmaceutical product.
The contract has an ultimate completion date of January 3, 2025 and a firm fixed price pricing type. It is not designated as a set-aside contract....
This contract award to AmerisourceBergen Drug Corp's Corporate Office division provides $10,127.09 for the delivery of 4565166028 - DEXAMETHASONE 20 MG/5 ML VIAL 5ML to the Defense Logistics Agency (DLA). The firm-fixed-price delivery order has a completion date of July 17, 2024 and does not utilize a set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, holds several indefinite delivery contracts (IDCs) with the DLA and other federal agencies to supply a wide range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The contract, valued at $1,059.75, is for the delivery of 4,565,815,786 units of Dexamethasone 20 mg/5 ml vials. This is a firm-fixed price delivery order contract with a completion date of September 17, 2024. The contract is not set-aside. AmerisourceBergen, a major supplier of pharmaceutical products and medical supplies to the U.S. federal...
This is a Delivery Order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of Amerisourcebergen Corporation. The $1,821.09 award is for the supply of 4,564,520,594 milliliters of dexamethasone 10 mg/ml vials. This Delivery Order is placed under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. The IDC allows DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,269.60 firm fixed price delivery order is for the supply of dexamethasone 10 mg/ml vials, a medication used for various medical conditions.
The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,467.71 firm fixed-price delivery order is for 4,566,340,664 units of the drug dexamethasone 20 mg/5 ml vial, with a performance period through November 6, 2024. The contract is not designated as a set-aside.
Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is for the delivery of 4560483454 DEXAMETHASONE 0.5 MG/5 ML ELX 237ML to the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $1,147.05 and was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order with a firm fixed price pricing type, and has an ultimate completion date of April 5, 2023. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a...